Tech Company Financing Transactions
Fortitude Biomedicines Funding Round
On 1/27/2026, Fortitude Biomedicines landed $13 million in Seed funding from Elikon Venture, K2VC and Shanghai Healthcare Capital.
Transaction Overview
Company Name
Announced On
1/27/2026
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to advance its lead immune cell targeting biologic program through IND-enabling studies and to leverage its proprietary GLUE-DAC� platform for discovering novel ADCs that utilize molecular glue payloads for oncology and autoimmune diseases.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
303 Wyman St 300
Waltham, MA 02451
US
Waltham, MA 02451
US
Phone
Website
Email Address
Overview
Fortitude Biomedicines is a private biotechnology company headquartered in Waltham, Massachusetts, pioneering next-generation immune cell targeting biologics and an antibody--drug conjugate (ADC) platform powered by proprietary molecular glue payloads. By integrating the precision targeting of ADCs with the catalytic power of targeted protein degradation, the company is developing transformative therapies with the potential to expand the therapeutic window of ADCs, overcome resistance mechanisms, and unlock new target space. Leveraging a robust discovery engine and an experienced team of drug hunters, Fortitude is building a differentiated pipeline of biologics and ADCs aimed at delivering meaningful benefits to patients with high unmet medical need.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jesse Chen
Chief Financial Officer
Keith Dewedoff
VP - Operations
Wendi Ni
Browse more venture capital transactions:
Prev: 1/27/2026: Yolando venture capital transaction
Next: 1/27/2026: TRexBio venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. All VC database entries on this site come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs